Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: A retrospective case-matched cohort series

Neurosurgery

Volumn 45, Issue 1, 1999, Pages 17-23

  Subach, Brian R ^a   Witham, Timothy F ^a   Kondziolka, Douglas ^a,b   Lunsford, L Dade ^a   Bozik, Michael ^a   Schiff, David ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

1,3 bis(2 chloroethyl) 1 Nitrosourea wafer; Chemotherapy; Glioblastoma multiforme; Implants

Indexed keywords

CARMUSTINE; POLYMER;

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

EID: 0032984584     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199907000-00004     Document Type: Article

References (21)

1. Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV: Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas. Am J Clin Oncol 20:364-367, 1997.
2. Brem H, Mahaley MS, Vick NA, Black KL, Schold SC Jr, Burger PC, Friedman AC, Ciric IS, Eller TW, Cozzens JW, Kenealy JN: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446, 1991.
3. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas: The Polymer-Brain Tumor Treatment Group. Lancet 345:1008-1012, 1995.
4. Brem H, Tamargo RJ, Olivi A, Pinn M, Weingart JD, Wharam M, Epstein JI: Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg 80:283-290, 1994.
5. Dang W, Daviau T, Brem H: Morphological characterization of polyanhydride biodegradable implant Gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm Res 13:683-691, 1996.
6. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275, 1993.
7. Domb AJ, Rock M, Perkin C, Yipchuck G, Broxup B, Villemure JG: Excretion of radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials 16:1069-1072, 1995.
8. Florell RC, MacDonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, Cairncross JG: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76:179-183, 1992.
9. Haines SJ: Six statistical suggestions for surgeons. Neurosurgery 9:414-118, 1981.
10. Hochberg FH, Pruitt AA, Beck DO, DeBrun G, Davis K: The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 63:876-880, 1985.
11. Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y: Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol 21:177-185, 1994.
12. Judy KD, Olivi A, Buahin KG, Domb A, Epstein JI, Colvin OM, Brem H: Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J Neurosurg 82:481-486, 1995.
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
14. Olivi A, Brem H: Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas. Recent Results Cancer Res 135:149-154, 1994.
15. Sipos EP, Brem H: New delivery systems for brain tumor therapy. Neurol Clin 13:813-825, 1995.
16. Sipos EP, Tyler B, Piantadosi S, Burger PC, Brem H: Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol 39:383-389, 1997.
17. Strasser JF, Fung LK, Eller S, Grossman SA, Saltzman WM: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. J Pharmacol Exp Ther 275:1647-1655, 1995.
18. Tenney JH, Vlahov D, Salcman M, Ducker TB: Wide variation in risk of wound infection following clean neurosurgery. J Neurosurg 62:243-247, 1985.
19. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto, Heiskanen O, Unsgaard G, Kuurne T: Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study. Neurosurgery 41:44-18, 1997.
20. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980.
21. Wu MP, Tamada JA, Brem H, Langer R: In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res 28:387-395, 1994.